| 1 |
34836491 | Evidence of off-target effects of bosutinib that promote retinoic acid-induced differentiation of non-APL AML cells. | 2021 Dec |
2 |
| 2 |
25641616 | Bosutinib, a Lyn/Btk inhibiting tyrosine kinase inhibitor, is ineffective in advanced systemic mastocytosis. | 2015 Apr |
1 |
| 3 |
21680801 | KIT-D816V-independent oncogenic signaling in neoplastic cells in systemic mastocytosis: role of Lyn and Btk activation and disruption by dasatinib and bosutinib. | 2011 Aug 18 |
2 |
| 4 |
19662183 | NS-187 (INNO-406), a Bcr-Abl/Lyn dual tyrosine kinase inhibitor. | 2007 Nov 14 |
1 |